1. Macaluso FS, Cummings JF, Atreya R, Choi J, Orlando A. A systematic review on infliximab biosimilar SB2: from pre-clinical data to real-world evidence. Expert Opin Biol Ther. 2022;22:203–23.
2. Valle E, Gross M, Bickston SJ. Infliximab. Expert Opin Pharmacother. 2001;2:1015–25.
3. Janssen Biologics. Remicade - Prescribing information 1998 [Available from: https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/REMICADE-pi.pdf.
4. Janssen Biologics. Remicade - Summary of Product Characterisitcs 1999 [Available from: https://www.ema.europa.eu/en/documents/product-information/remicade-epar-product-information_en.pdf.
5. Melsheimer R, Geldhof A, Apaolaza I, Schaible T. Remicade(®) (infliximab): 20 years of contributions to science and medicine. Biologics. 2019;13:139–78.